News Archive Archives - Page 2 of 725

June 25th, 2017

IGT, Paradise Entertainment sign ETG patent deal

Apr 26, 2016 | Deals, News Archive, Uncategorized

Hong Kong-listed Paradise Entertainment Ltd has agreed to transfer all of its electronic table game (ETG) technology, patents and other intellectual property to global gaming supplier International Game Technology Plc (IGT), with the exception of table game...

Protea, Yale Ink License Agreement

Apr 25, 2016 | Bio, Deal News, Deals, News Archive, Uncategorized, University Tech Transfer

NEW YORK – Protea Biosciences has licensed a mass spectrometry-based technology from Yale University aimed at improving diagnosis of melanoma. The Morgantown, West Virginia-based firm is developing a test that will use proteomic mass spec imaging (MSI),...

LG Chem Licensing From Optodot

Apr 25, 2016 | Bio, Deal News, Deals, News Archive, Uncategorized

Optodot Corporation and LG Chem have signed a new patent license agreement that will see the lithium-ion battery manufacturer granted the right to utilize the boehmite separators developed by Optodot, according to a new press...

Horizon Pharma Strikes License Deal With Amneal Pharmaceuticals

Apr 25, 2016 | Bio, Deal News, Deals, News Archive, Uncategorized

Horizon Pharma (NASDAQ:HZNP) said it has entered a settlement and license agreement with Amneal Pharmaceuticals to resolve pending patent litigation regarding Pennsaid 2%. Under the agreement, Horizon has granted Amneal the non-exclusive right to market a...

AMD strikes chip licensing deal

Apr 24, 2016 | Deals, News Archive, Uncategorized

AMD has announced a plan to license the design of its top-of-the-line server processor to a newly formed Chinese company, creating a brand-new rival for Intel. AMD is licensing its x86 processor and system-on-chip technology to a company called THATIC (Tianjin...

AbbVie (ABBV), argenx Enter Collaboration

Apr 21, 2016 | Bio, Deal News, Deals, News Archive, Uncategorized

AbbVie (NYSE: ABBV) and argenx, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies to treat cancer and severe autoimmune diseases will collaborate to develop and commercialize ARGX-115. ARGX-115...

« Older Entries

Next Entries »

Recent Tweets

RT @TechCrunch: HEBI is trying to make building custom robots as easy as playing with LEGO https://t.co/sGFLjwlmf1 https://t.co/elfr7vxyWg7 hours ago
We invite @unifiedpatents to a rebuttal to this or any of our upcoming articles on this topic-we are fair & balance… https://t.co/8dzxTVc7rayesterday
Slow weekend before the big July 4th build up (at least here in the US). Go back and re-watch @thebigshort gentle reminder...stay alertyesterday
RT @Pandersonpllc: Professor Chien says infringers want certainty. BS. They want to delay and obfuscate.yesterday
Stay informed. And stay involved. Good graphic - thanks for sharing. https://t.co/yTi8fCA4nGyesterday

IGT, Paradise Entertainment sign ETG patent deal

Protea, Yale Ink License Agreement

LG Chem Licensing From Optodot

Horizon Pharma Strikes License Deal With Amneal Pharmaceuticals

AMD strikes chip licensing deal

AbbVie (ABBV), argenx Enter Collaboration

Latest Stories

STRONGER Patents Act Promises Bi-Partisan Congressional Support For Patent Owners

IP Bridge Enters into New Patent License Agreement for IP Bridge’s Wireless Telecom Standard-Essential Patents

US court grants Elsevier millions in damages from Sci-Hub

How Cisco’s IP Strategy to Stop Arista Went Bust

Cipla, Roche Settle Cancer Drug Patent Case

Recent Tweets

Subscribe to get the latest news